Literature DB >> 29634401

Modulation of mRNA Translation and Cell Viability by Influenza A Virus Derived Nonstructural Protein 1.

Yi Liu1, Zhen Hua Chia1, Johannes Nathaniel Min Hui Liew1, Shi Min Or1, Kyle K L Phua1.   

Abstract

Translation of in vitro transcribed messenger RNA (mRNA) is known to be compromised by cell's innate immune responses. Herein we show that when mRNA encoding nonstructural protein 1 (NS1), an immune evasion gene derived from influenza A virus, is co-delivered with mRNA encoding green fluorescent protein (GFP), higher GFP expression can be observed in four different interferon competent cell types within 6 h, indicating NS1's wide host range property and rapid counter response to the cells' innate immune response. Enhanced mRNA translation correlates with reduced interferon production in all tested cell types and substituting a small portion of luciferase mRNA with NS1 mRNA enhances luciferase production compared to the same dose composing of only luciferase mRNA although in a cell type specific manner. Toxicity caused by transfection of unmodified mRNA is mitigated with the delivery of NS1 mRNA and is observed only in NS1 without cleavage and polyadenylation specificity factor 30 kda (CPSF30) inhibition function. Conversely, delivery of mRNA encoding NS1 with CPSF30 inhibition function aggravated toxicity. Overall, we demonstrate that NS1 enhanced mRNA transfection through active evasion of innate immune responses and modulated cellular viability during mRNA transfection.

Entities:  

Keywords:  immune evasion; mRNA delivery; transfection

Mesh:

Substances:

Year:  2018        PMID: 29634401      PMCID: PMC5994669          DOI: 10.1089/nat.2017.0712

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  39 in total

1.  Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells.

Authors:  Oliwia Andries; Marina De Filette; Stefaan C De Smedt; Jo Demeester; Mario Van Poucke; Luc Peelman; Niek N Sanders
Journal:  J Control Release       Date:  2013-02-08       Impact factor: 9.776

2.  mRNA is an endogenous ligand for Toll-like receptor 3.

Authors:  Katalin Karikó; Houping Ni; John Capodici; Marc Lamphier; Drew Weissman
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

Review 3.  The interferon system and vaccinia virus evasion mechanisms.

Authors:  Beatriz Perdiguero; Mariano Esteban
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

4.  Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.

Authors:  Lena M Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai; Kerstin C Reuter; Martin Meng; Daniel Fritz; Fulvia Vascotto; Hossam Hefesha; Christian Grunwitz; Mathias Vormehr; Yves Hüsemann; Abderraouf Selmi; Andreas N Kuhn; Janina Buck; Evelyna Derhovanessian; Richard Rae; Sebastian Attig; Jan Diekmann; Robert A Jabulowsky; Sandra Heesch; Jessica Hassel; Peter Langguth; Stephan Grabbe; Christoph Huber; Özlem Türeci; Ugur Sahin
Journal:  Nature       Date:  2016-06-01       Impact factor: 49.962

5.  Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format.

Authors:  Kyle K L Phua; Kam W Leong; Smita K Nair
Journal:  J Control Release       Date:  2013-01-07       Impact factor: 9.776

6.  NS1-binding protein abrogates the elevation of cell viability by the influenza A virus NS1 protein in association with CRKL.

Authors:  Masaya Miyazaki; Hiroshi Nishihara; Hideki Hasegawa; Masato Tashiro; Lei Wang; Taichi Kimura; Mishie Tanino; Masumi Tsuda; Shinya Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2013-11-09       Impact factor: 3.575

Review 7.  Viral mechanisms of immune evasion.

Authors:  A Alcami; U H Koszinowski
Journal:  Immunol Today       Date:  2000-09

8.  A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence.

Authors:  Juan Ayllon; Patricia Domingues; Ricardo Rajsbaum; Lisa Miorin; Mirco Schmolke; Benjamin G Hale; Adolfo García-Sastre
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

Review 9.  Shutoff of Host Gene Expression in Influenza A Virus and Herpesviruses: Similar Mechanisms and Common Themes.

Authors:  Hembly G Rivas; Summer K Schmaling; Marta M Gaglia
Journal:  Viruses       Date:  2016-04-16       Impact factor: 5.048

Review 10.  Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines.

Authors:  Kyle K L Phua
Journal:  J Immunol Res       Date:  2015-12-24       Impact factor: 4.818

View more
  2 in total

1.  Dual R108K and G189D Mutations in the NS1 Protein of A/H1N1 Influenza Virus Counteract Host Innate Immune Responses.

Authors:  Meng-Ting Huang; Sen Zhang; Ya-Nan Wu; Wei Li; Yu-Chang Li; Chang-Shuai Zhou; Xiao-Ping Kang; Tao Jiang
Journal:  Viruses       Date:  2021-05-13       Impact factor: 5.048

Review 2.  Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.

Authors:  An-Katrien Minnaert; Helena Vanluchene; Rein Verbeke; Ine Lentacker; Stefaan C De Smedt; Koen Raemdonck; Niek N Sanders; Katrien Remaut
Journal:  Adv Drug Deliv Rev       Date:  2021-07-26       Impact factor: 17.873

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.